HALAZONE SODIUM

Details

Stereochemistry	ACHIRAL
Molecular Formula	C7H4Cl2NO4S.Na
Molecular Weight	292.072
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Na+].[O-]C(=O)C1=CC=C(C=C1)S(=O)(=O)N(Cl)Cl

InChI

InChIKey=QTHWRGNWAMGOMB-UHFFFAOYSA-M

InChI=1S/C7H5Cl2NO4S.Na/c8-10(9)15(13,14)6-3-1-5(2-4-6)7(11)12;/h1-4H,(H,11,12);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula	Na
Molecular Weight	22.98976928
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C7H4Cl2NO4S
Molecular Weight	269.082
Charge	-1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Carbonic anhydrase II 88 Target ID: CHEMBL205 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16858005	Inhibitor 8504		1.45 µM [Kd]

PubMed

Title	Date	PubMed
FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1.	2013-09-05	23769903
Inhibition profiling of human carbonic anhydrase II by high-throughput screening of structurally diverse, biologically active compounds.	2006-10	16858005

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:18:28 GMT 2025` Edited by `admin` on `Mon Mar 31 23:18:28 GMT 2025`
Record UNII	PZE672762W
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

HALAZONE SODIUM

Common Name

English

PANTOSEPT

Preferred Name

English

BENZOIC ACID, P-(DICHLOROSULFAMOYL)-, SODIUM SALT

Common Name

English

BENZOIC ACID, 4-((DICHLOROAMINO)SULFONYL)-, SODIUM SALT

Common Name

English

NSC-163513

Code

English

BENZOIC ACID, 4-((DICHLOROAMINO)SULFONYL)-, SODIUM SALT (1:1)

Systematic Name

English

SODIUM P-DICHLOROSULFAMIDOBENZOATE

Common Name

English

PANTOCID-SODIUM

Common Name

English

Code System Code Type Description

ECHA (EC/EINECS)

227-176-3